Publication | Closed Access

Randomized trial comparing the tolerability of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in cancer patients receiving myelosuppressive chemotherapy

Hematological MalignancyBacteria-derived Rhug-csfMedicineClinical TrialsPathologyPharmacotherapyYeast-derived Rhugm-csfCancer PatientsCancer TreatmentOncologyRadiation OncologyCancer ResearchHealth Sciences